Canakinumab (Ingredient)
Drugbank ID: DB06168
ATC code: L04AC08
The information below refers to products available in the United States that contain canakinumab.
Products containing canakinumab
canakinumab systemic
Brand name: Ilaris
Drug class: interleukin inhibitors
Canakinumab systemic is used in the treatment of:
- Cryopyrin-Associated Periodic Syndromes
- Familial Cold Autoinflammatory Syndrome
- Familial Mediterranean Fever
- Gout, Acute
- Hyperimmunoglobulin D Syndrome
- Juvenile Idiopathic Arthritis
- Muckle Wells Syndrome
- Still's Disease
- Tumor Necrosis Factor Receptor Associated Periodic Syndrome
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
